Viracta Therapeutics Quote - VIRX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.0301

Bid

0.0267

Ask

0.0367

Volume

0.00 Day's Range 0.00

0.0301 52 Week Range 1.31

Market Cap

1.196M

Previous Close

0.0301

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,699,096

Shares Outstanding

39,744,222

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-1.28

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was US$0.03. Over the last year, Viracta Therapeutics shares have traded in a share price range of US$ 0.0301 to US$ 1.31.

Viracta Therapeutics currently has 39,744,222 shares outstanding. The market capitalization of Viracta Therapeutics is US$1.20 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1299	-81.1875	0.16	0.16	0.0301	3763237	0.06736288	CS
4	-0.1589	-84.0740740741	0.189	0.1969	0.0301	1640321	0.10129022	CS
12	-0.1358	-81.8565400844	0.1659	0.257406	0.0301	2699096	0.16596214	CS
26	-0.3999	-93	0.43	0.56	0.0301	1888794	0.20428837	CS
52	-0.5899	-95.1451612903	0.62	1.31	0.0301	997325	0.23308021	CS
156	-2.4199	-98.7714285714	2.45	5.75	0.0301	447037	0.77651072	CS
260	-16.7299	-99.8204057279	16.76	18.24	0.0301	404370	2.0569835	CS

VIRX - Frequently Asked Questions (FAQ)

What is the current Viracta Therapeutics share price?

The current share price of Viracta Therapeutics is US$ 0.0301

How many Viracta Therapeutics shares are in issue?

Viracta Therapeutics has 39,744,222 shares in issue

What is the market cap of Viracta Therapeutics?

The market capitalisation of Viracta Therapeutics is USD 1.2M

What is the 1 year trading range for Viracta Therapeutics share price?

Viracta Therapeutics has traded in the range of US$ 0.0301 to US$ 1.31 during the past year

What is the PE ratio of Viracta Therapeutics?

The price to earnings ratio of Viracta Therapeutics is -0.02

What is the reporting currency for Viracta Therapeutics?

Viracta Therapeutics reports financial results in USD

What is the latest annual profit for Viracta Therapeutics?

The latest annual profit of Viracta Therapeutics is USD -51.06M

What is the registered address of Viracta Therapeutics?

The registered address for Viracta Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Viracta Therapeutics website address?

The website address for Viracta Therapeutics is www.viracta.com

Which industry sector does Viracta Therapeutics operate in?

Viracta Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 16.96 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 74.56 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.90 (0.00%)	0
AACGATA Creativity Global	US$ 0.80 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.96 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 74.56 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.90 (0.00%)	0
AACGATA Creativity Global	US$ 0.80 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.96 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 74.56 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.90 (0.00%)	0
AACGATA Creativity Global	US$ 0.80 (0.00%)	0